Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Interview.
- Who it may be relevant to
- Registry conditions: Leukemia, Non Hodgkin Lymphoma. Basic parameters: up to 22 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Improving Communication With and Building a Stronger Medical Home Among Spanish-speaking Families in the Center for Cancer and Blood Disorders
Overview
This study will seek to improve communication with Spanish speaking families and patients with Cancer and Blood Disorders.
Detailed description
The Principal Investigator seeks to improve communication with Spanish speaking families with the following goals: 1) to increase patient and family sense of inclusion in the medical community, 2) to increase patient and family medical knowledge and understanding, 3) to improve patient adherence with critical medical regimens, and ultimately, 4) to increase equality of comprehensive medical care delivery across the continuum of care including physical and psychosocial domains.
Interventions
- Other Interview
Patient/parent dyads expressing interest will be interviewed by a bilingual Spanish certified provider via televideo with as needed interpreter support. Interviews will be audio recorded for review and translation purposes and then will be destroyed. Interview format will be supportive and information seeking only with reassurance that purpose is for care improvement and that all answers will be evaluated without association to patient name. Interviews will then be translated and reviewed by the
Primary outcome measures
- Determine a baseline level of Spanish speaking patient satisfaction of care [Time frame: 12 months]
- Determine a baseline level of Spanish Speaking family satisfaction of care [Time frame: 12 months]
- Determine effects of language barrier on Spanish speaking patient needs [Time frame: 12 months]
- Determine the effect of language barrier on barriers to patient care [Time frame: 12 months]
- Effect of language barrier on efficiency of access to care [Time frame: 12 months]
Secondary outcome measures (6)
- Determine patient interest in home telemedicine support program [Time frame: 12 months]
- Determine patient interest in home telemedicine support program after discharge [Time frame: 12 months]
- Determine Spanish speaking patient interest in telemedical check-ins during intensive phases of therapy [Time frame: 12 months]
- Determine Spanish speaking patient interest in medication assistance during intensive phases of therapy [Time frame: 12 months]
- Determine Spanish speaking patient interest in medical check-ins during maintenance [Time frame: 12 months]
- Determine Spanish speaking patient interest in medication assistance during maintenance [Time frame: 12 months]
Eligibility criteria
Inclusion criteria
- 0 to 22 years of age
- Diagnosis of leukemia or non-Hodgkin lymphoma
- Spanish as preferred language for patient, parent or guardian
- Received or receiving care at the Center for Cancer and Blood Disorders (CCBD)
Exclusion criteria
- Patients without oncologic diagnosis
- Patients with parents whose language preference is English
- Patients who received care solely outside of the CCBD
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- Children's Hospital Colorado — Aurora
Identifiers
NCT: NCT05425992 · 21-4238.cc · NCI-2022-04061